Editas Medicine

300 Third Street, First Floor

Cambridge, MA  02142


Website:
www.editasmedicine.com


Information:
info@editasmed.com

Editas Medicine

Flagship Partners:  Doug Cole
Initial Investment: 
2013
Status: 
Private

Editas Medicine is a transformative genome editing company founded by five world leaders in the fields of genome editing, protein engineering, and molecular and structural biology, with specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Doug Cole is on the Board of Directors.